tm
Seeing Is Believing
tm
Seeing Is Believing
CVKD is currently covered by 1 analysts with an average price target of $13. This is a potential upside of $11.88 (1060.71%) from yesterday's end of day stock price of $1.12.
Cadrenal Therapeutics, Common Stock's activity chart (see below) currently has 1 price targets and 2 ratings on display. The stock rating distribution of CVKD is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 12.5% with an average time for these price targets to be met of 473.5 days.
Highest price target for CVKD is $13, Lowest price target is $13, average price target is $13.
Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 07-Apr-2026. First documented stock forecast 20-Nov-2023.
Currently out of the existing stock ratings of CVKD, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 16-May-2025
$13
$11.85 (1030.43%)
$32
5 months 22 days ago
(07-Apr-2026)
0/2 (0%)
$8.68 (200.93%)
What is CVKD (Cadrenal Therapeutics, Common Stock) average time for price targets to be met?
Which analyst most recently updated their price target on CVKD (Cadrenal Therapeutics, Common Stock)?
Which analyst has the most public recommendations on CVKD (Cadrenal Therapeutics, Common Stock)?
Which analyst is the currently most bullish on CVKD (Cadrenal Therapeutics, Common Stock)?
Which analyst is the currently most reserved on CVKD (Cadrenal Therapeutics, Common Stock)?
